Novartis AG is 301.2x more valuable than Corvus Pharmaceuticals, Inc. by market capitalization ($282.64 B vs $938.45 M). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CRVS | NVS |
|---|---|---|
| Market cap | $938.45 M | $282.64 B |
| US-listed rank | #2646 | #47 |
| Net income (latest FY) | -$15.30M | - |
| SEC filings | 570 | 947 |
Novartis AG is 301.2x more valuable than Corvus Pharmaceuticals, Inc. by market capitalization ($282.64 B vs $938.45 M).
Full pages: Corvus Pharmaceuticals, Inc. and Novartis AG, or browse the full rankings.